EUVIMEDEUVIMED entdecken
Crossref

Design and characterization of 4D-710, an aerosolized gene therapy for cystic fibrosis lung disease

Melissa A Calton, Roxanne H Croze, Theodore H Sullivan, Sara A Collins, Sarah Tucker, Kevin J Whittlesey, Daniel H Kim, Julie A Nye, Ghezal Beliakoff, Melissa Quezada, Christian Burns, Chris Schmitt und 18 weitere

American Journal of Respiratory Cell and Molecular Biology · 01.07.2026 · 74 (7) · 837-846

DOI: 10.1165/rcmb.2025-0243ma ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, online erschienen am 22.10.2025. Verfasst von Melissa A Calton und 29 weiteren Autor:innen. Beteiligte Einrichtung: 4D Molecular Therapeutics, Emeryville, CA, United States. Hauptthemen laut MEDLINE: Cystic Fibrosis, Genetic Therapy, Cystic Fibrosis Transmembrane Conductance Regulator, Dependovirus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis (CF) is an autosomal recessive disease caused by variants in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Delivery of a functional CFTR transgene to airway epithelial cells (AEC) offers the potential to provide durable restoration of normal CFTR function. Adeno-associated virus (AAV) vectors are the leading platform for the delivery of in vivo gene therapy; however, wild-type AAV vectors exhibit a limited capacity to transduce airway cells and evade pre-existing human neutralizing antibodies (NAb). We therefore employed a directed evolution platform to invent a novel AAV capsid (A101) with the capacity to efficiently transduce AECs, including in the presence of NAbs, following aerosolized administration to nonhuman primates (NHP). We then engineered 4D-710, a gene therapy comprising the A101 vector and a CFTR transgene with a partial deletion in the regulatory domain (CFTRΔR) to facilitate vector packaging. 4D-710 exhibited efficient transduction of human bronchial epithelial (HBE) cell air–liquid interface (ALI) cultures in vitro and robust functional activity in CF HBE ALI cultures. Aerosolized administration of 4D-710 to NHPs was well tolerated and resulted in dose-dependent transgene expression and increased CFTR protein in diverse AEC types compared with vehicle controls. No significant differences in CFTRΔR mRNA levels were observed in lung samples from NHPs with pre-existing serum anticapsid NAbs compared with NAb-negative NHPs. These findings demonstrate the tolerability and feasibility of A101-mediated transgene delivery and expression in primate airways. A clinical trial evaluating aerosol delivery of 4D-710 in adults with CF (NCT05248230) is underway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisGenetic TherapyCystic Fibrosis Transmembrane Conductance RegulatorDependovirusHumansAnimalsGenetic VectorsAerosolsGene Therapy AgentsEpithelial CellsTransgenesTransduction, Genetic

Stichwörter der Autor:innen

CFTRadeno-associated virusdirected evolutionvectors

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorAerosolsCFTR protein, human

Autor:innen und Institutionen

  • 4D Molecular Therapeutics, Emeryville, CA, United States.
  • Department of Bioengineering, University of California, Berkeley, CA, United States.
  • Divisions of Pulmonary Sciences and Critical Care Medicine and Pediatric Pulmonology, National Jewish Health, Denver, CO, United States.

ORCID-Profile: Jennifer L Taylor-Cousar

Zitieren

APA

Calton, M. A., Croze, R. H., Sullivan, T. H., Collins, S. A., Tucker, S., Whittlesey, K. J., Kim, D. H., Nye, J. A., Beliakoff, G., Quezada, M., Burns, C., Schmitt, C., Klein, A., Jia, V., Kovacs, L., Lauko, D., Yoh, K., Nguyen, K., Barglow, K., …, & Kirn, D. (2026). Design and characterization of 4D-710, an aerosolized gene therapy for cystic fibrosis lung disease. American Journal of Respiratory Cell and Molecular Biology, 74(7), 837-846. https://doi.org/10.1165/rcmb.2025-0243ma

Vancouver

Calton MA, Croze RH, Sullivan TH, Collins SA, Tucker S, Whittlesey KJ, et al. Design and characterization of 4D-710, an aerosolized gene therapy for cystic fibrosis lung disease. American Journal of Respiratory Cell and Molecular Biology. 2026;74(7):837-846. doi:10.1165/rcmb.2025-0243ma

BibTeX
@article{Calton2026,
  author = {Calton, Melissa A and Croze, Roxanne H and Sullivan, Theodore H and Collins, Sara A and Tucker, Sarah and Whittlesey, Kevin J and Kim, Daniel H and Nye, Julie A and Beliakoff, Ghezal and Quezada, Melissa and Burns, Christian and Schmitt, Chris and Klein, Austin and Jia, Vicky and Kovacs, Laura and Lauko, Domokos and Yoh, Kathryn and Nguyen, Kien and Barglow, Katherine and Gonzales, Johnny and Khoday, Devi and Mason, Thomas and Delaria, Kathy and Bashour, Keenan and Kotterman, Melissa and Schaffer, David and Song, An and Francis, Peter and Taylor-Cousar, Jennifer L and Kirn, David},
  title = {Design and characterization of 4D-710, an aerosolized gene therapy for cystic fibrosis lung disease},
  journal = {American Journal of Respiratory Cell and Molecular Biology},
  year = {2026},
  volume = {74},
  number = {7},
  pages = {837--846},
  doi = {10.1165/rcmb.2025-0243ma}
}
Kostenlos starten →